Just as good quality data is essential to draw the right conclusions from experiments, so are good quality compounds. There are many ways to assess compound quality and one technique we regularly use for this purpose at ZoBio is NMR.
We start by dissolving incoming compounds in d6-DMSO to generate stock solutions for use in various assays. The advantage of using d6-DMSO is that the same stock can not only be used for biochemical and SPR assays, but also for ligand- or protein observed NMR. This way, we reduce batch to batch variance…
ZoBio Awarded the Company Showing Best Growth Results!
At the recent annual network event organized by Libertatis Ergo Holding BV (LEH) at Leiden Bio Science Park (LBSP) ZoBio was awarded #1 company in the category: Company showing best growth results!
On the premises of LBSP more than 150 biomedical life science companies…
RICT 2023: 57th International Conference on Medicinal Chemistry
In person ZoBio was present in Lille at 57th International Conference on Medicinal Chemistry. The event is organized yearly by the French Medicinal Chemistry Society (Société de Chimie Thérapeutique – SCT). As for the previous editions of RICT, the scientific committee ensured the high quality and diversity of the scientific program. ZoBio was represented by Anna Belorusova,…
ACSMEDI-EFMC Medicinal Chemistry Frontiers 2023
In person From 10 to 13 June Michael Nyman attended ACSMEDI-EFMC Medicinal Chemistry Frontiers symposium in Boston. The conference was co-organized as a collaboration between the ACS (American Chemical Society), MEDI (Division of Medicinal Chemistry) and the EFMC (European Federation for Medicinal Chemistry and Chemical Biology). The meeting attracted a highly targeted audience composed of experts, researchers and…